The relationship between cardiac injury, inflammation and coagulation in predicting COVID-19 outcome

Area of Science:

• Cardiology
• Infectious Diseases
• Critical Care Medicine

Background:

• High sensitivity troponin T (hsTnT) is a key predictor of adverse outcomes in SARS-CoV-2 infection.
• The specific factors influencing hsTnT levels in COVID-19 patients are not fully understood.
• Investigating the interplay between inflammation, coagulation, and hsTnT is crucial for risk stratification.

Purpose of the Study:

• To determine the relationship between inflammatory markers, coagulation abnormalities, and hsTnT levels in hospitalized COVID-19 patients.
• To assess the role of these pathways in predicting mortality and complications.
• To evaluate the impact of treatments on mitigating these risks.

Main Methods:

• A prospective, observational study involving 266 patients hospitalized with SARS-CoV-2 pneumonia.
• Measurement of hsTnT, D-dimer, C-reactive protein (CRP), and arterial blood gas (PaO2).
• Statistical analysis to assess associations between biomarkers, mortality, and treatment effects.

Main Results:

• hsTnT levels were independently associated with in-hospital mortality.
• D-dimer and CRP showed stronger correlations with hsTnT than PaO2.
• Low molecular weight heparin treatment was associated with reduced mortality, particularly in patients with elevated hsTnT.

Conclusions:

• SARS-CoV-2-associated coagulopathy significantly contributes to hsTnT elevation and mortality.
• D-dimer is a critical biomarker linking coagulation, hsTnT, and adverse outcomes.
• Anticoagulation therapy demonstrates potential benefits in managing COVID-19 patients at high risk.